Showing results (1181-1190 of 1,298) with videos related to

Sort By:
Pageof 130
Environmental Health Perspectives|January 20, 2018
Long-Term Exposure to Fine Particulate Matter, Blood Pressure, and Incident Hypertension in Taiwanese AdultsZilong Zhang, Cui Guo, Alexis K H Lau, et al.
The Lancet Regional Health. Western Pacific|June 18, 2025
Population-level productivity-adjusted life years lost in individuals with type 2 diabetes in Hong Kong: a life table modelling studyHongjiang Wu, Haobin Zhou, Chuiguo Huang, et al.
International Journal of Hygiene and Environmental Health|October 15, 2017
Particulate matter air pollution, physical activity and systemic inflammation in Taiwanese adultsZilong Zhang, Gerard Hoek, Ly-Yun Chang, et al.
Neoplasma|April 1, 2010
Overexpression of clusterin correlates with tumor progression, metastasis in gastric cancer: a study on tissue microarraysJ Bi, A L Guo, Y R Lai, et al.
Heart Rhythm|April 14, 2010
Cardiac expression of skeletal muscle sodium channels increases longitudinal conduction velocity in the canine 1-week myocardial infarctionRuben Coronel, David H Lau, Eugene A Sosunov, et al.
Plos One|September 10, 2013
Atrial arrhythmia in ageing spontaneously hypertensive rats: unraveling the substrate in hypertension and ageingDennis H Lau, Nicholas J Shipp, Darren J Kelly, et al.
Materials (Basel, Switzerland)|April 12, 2022
Characterization of Low-Loss Dielectric Materials for High-Speed and High-Frequency ApplicationsTzu-Nien Lee, John-H Lau, Cheng-Ta Ko, et al.
Diabetes/Metabolism Research and Reviews|September 18, 2025
Development of a Chinese-Specific Clinical Model to Predict Maturity-Onset Diabetes of the YoungSandra T F Tsoi, Cadmon K P Lim, Ronald C W Ma, et al.
Clinical Pharmacology and Therapeutics|October 16, 2021
CYP2C19 Loss-of-function Polymorphisms are Associated with Reduced Risk of Sulfonylurea Treatment Failure in Chinese Patients with Type 2 DiabetesKe Wang, Aimin Yang, Mai Shi, et al.
Cancer Journal (Sudbury, Mass.)|November 9, 2004
An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in CaliforniaCynthia L Martel, Yueju Li, Laurel Beckett, et al.
Pageof 130